Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2017 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes.
Björnsson ES, Gu J, Kleiner DE, Chalasani N, Hayashi PH, Hoofnagle JH; DILIN Investigators. Björnsson ES, et al. J Clin Gastroenterol. 2017 Jan;51(1):63-69. doi: 10.1097/MCG.0000000000000568. J Clin Gastroenterol. 2017. PMID: 27648552 Free PMC article. Clinical Trial.
OBJECTIVE: The objective of the study was to define the clinical, biochemical, and histologic features of liver injury from thiopurines. BACKGROUND: Azathioprine (Aza) and 6-mercaptopurine (6-MP) can cause liver in
OBJECTIVE: The objective of the study was to define the clinical, biochemical, and histologic features of liver inju
Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn's disease.
Błogowski W, Marlicz W, Smereczyński A, Lawniczak M, Lewosiuk A, Starzyńska T. Błogowski W, et al. Immunopharmacol Immunotoxicol. 2011 Jun;33(2):398-402. doi: 10.3109/08923973.2010.509727. Epub 2010 Aug 21. Immunopharmacol Immunotoxicol. 2011. PMID: 20726808
Currently (3 years after diagnosis) remission of Crohn's disease is achieved, however, progression of features of portal hypertension is observed. ...Our Case Study highlights the clinical difficulties and challenges associated with diagnosing of azathiopr
Currently (3 years after diagnosis) remission of Crohn's disease is achieved, however, progression of features of portal hyper …
Feedback